Plain-English translation of NCT06508190 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding a daily walking routine to standard sleep apnea treatment (using a CPAP breathing machine) can help improve your sleep quality, reduce exhaustion, and support your liver health. You'll be compared to patients who use only the CPAP machine without added exercise. The study involves 40 patients total and lasts 12 weeks.
Many people with both sleep apnea and fatty liver disease struggle with fatigue and poor sleep quality, and their liver function may worsen. Researchers want to see whether the combination of breathing therapy and regular exercise might work better than breathing therapy alone to address all these problems at once.
You'll be randomly assigned to one of two groups for 12 weeks. Both groups will use a CPAP breathing machine for at least 4 hours each night. If you're in the walking group, you'll also walk for 30 minutes every day, seven days a week. The study will measure changes in your liver function, energy levels, and sleep quality before and after the 12 weeks.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt
Sponsor
Ahram Canadian University
Enrollment target
~40 participants
Started
July 2024
Primary completion
December 2024
Age range
40 Years – 65 Years
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
El-Hadidy Hagar, PHD
Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt